| Original language | English |
|---|---|
| Pages (from-to) | S2130-S2132 |
| Number of pages | 3 |
| Journal | Journal of thoracic disease |
| Volume | 10 |
| Issue number | Supp 18 |
| DOIs | |
| Publication status | Published - Jul-2018 |
Keywords
- CRIZOTINIB
- RESISTANCE
- INHIBITOR
Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?
Anthonie J. van der Wekken*, Klaas Kok, Harry J. M. Groen
*Corresponding author for this work
Research output: Contribution to journal › Editorial › Academic › peer-review
1
Citation
(Scopus)